SIGA Technologies Inc. Common Stock
SIGA US8269171067
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Varma Jay CMO |
7.86 USD |
7,414 Sold |
58,274 USD |
11/06/2024 | 11/06/2024 |
Nabel Gary J. |
7.86 USD |
7,414 Sold |
58,274 USD |
11/06/2024 | 11/06/2024 |
Durnan Jaymie A |
7.86 USD |
7,414 Sold |
58,274 USD |
11/06/2024 | 11/06/2024 |
Knisely Evan A. |
7.86 USD |
7,414 Sold |
58,274 USD |
11/06/2024 | 11/06/2024 |
Nemirovsky Julian |
7.86 USD |
7,414 Sold |
58,274 USD |
11/06/2024 | 11/06/2024 |
Phillips Holly L. |
7.86 USD |
7,414 Sold |
58,274 USD |
11/06/2024 | 11/06/2024 |
Ford Harold Eugene Jr. |
7.86 USD |
7,414 Sold |
58,274 USD |
11/06/2024 | 11/06/2024 |
Marshall Joseph W Iii |
7.86 USD |
7,414 Sold |
58,274 USD |
11/06/2024 | 11/06/2024 |